![Genetic lottery: Excuse to do nothing or do everything? | Science | In-depth reporting on science and technology | DW | 23.09.2021 Genetic lottery: Excuse to do nothing or do everything? | Science | In-depth reporting on science and technology | DW | 23.09.2021](https://static.dw.com/image/55220170_7.png)
Genetic lottery: Excuse to do nothing or do everything? | Science | In-depth reporting on science and technology | DW | 23.09.2021
![Establishment of human fetal hepatocyte organoids and CRISPR–Cas9-based gene knockin and knockout in organoid cultures from human liver | Nature Protocols Establishment of human fetal hepatocyte organoids and CRISPR–Cas9-based gene knockin and knockout in organoid cultures from human liver | Nature Protocols](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41596-020-00411-2/MediaObjects/41596_2020_411_Fig1_HTML.png)
Establishment of human fetal hepatocyte organoids and CRISPR–Cas9-based gene knockin and knockout in organoid cultures from human liver | Nature Protocols
![Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes | Nature Communications Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26806-7/MediaObjects/41467_2021_26806_Fig1_HTML.png)